Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Floridienne S.A. is a diversified industrial holding company operating in the sectors of Life Sciences, Gourmet Food, and Chemicals. It holds leading positions in various niche markets, focusing on specialty chemicals, recycling, natural products for agriculture, and high-quality food processing. The Life Sciences division, through subsidiaries like Biobest, provides biological solutions such as integrated pest management, pollination products, plant-based enzymes, and olfactory solutions for agriculture, cosmetics, and health applications. The Gourmet Food division specializes in premium products including escargots, truffles, scallops, salads, and fish spreads. The Chemicals division manufactures stabilizers like calcium-zinc and heavy metal-free variants for PVC applications, alongside waste recycling for batteries and galvanization residues. With operations spanning Europe and the Americas, Floridienne S.A. manages numerous subsidiaries and plants, emphasizing sustainable and innovative industrial processes. Founded in 1898 and headquartered in Waterloo, Belgium, it serves global markets in these specialized segments.
€60.00
€0.50 (-0.83%)
EOD Jun 23, 2026 · Twelve Data
Operating margin is thin at 8.50%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 4.1%, steady but not accelerating. Free cash flow declined 67% despite revenue growth, conversion is weakening.
At 74x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 67% versus the prior year, cash generation momentum has weakened.
74.0x earnings, 142.7x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€726M
▲ +4.1% YoY
Net Income (TTM)
€15M
▼ -51.2% YoY
Op. Margin
8.50%
▼ -1.9pp YoY
ROIC
4.13%
▼ -0.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€8M
▼ -66.7% YoY
Op. Cash Flow (TTM)
€49M
▼ -36.9% YoY
Net Debt
€304M
Cash & Equiv.
€93M
3Y CAGR: +11.9%
3Y CAGR: +55.1%
Continue Research
At a P/E of 74.0 and a price-to-free-cash-flow of 142.7, Floridienne (FLOB.XBRU) trades above a two-stage DCF intrinsic value of about €-9.06 per share, so at €60.00 the stock looks overvalued (115.1% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Floridienne scores 54/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 0.3%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €-9.06 per share for FLOB.XBRU, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €-6.80. At today's €60.00, that puts the stock about 115.1% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Floridienne scores 54 out of 100 on Intrinsiqq's quality score, passing 3 of 8 checks, which makes it a mixed business on these measures. Recent fundamentals include a 8.5% operating margin and a 4.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
Yes, Floridienne pays a regular dividend of about €0.16 per share per year (typically in quarterly installments), a yield of roughly 0.3% at the current price. That is a payout ratio of about 19.5% of earnings, so the dividend is amply covered by earnings. Floridienne has grown the dividend at roughly 6.9% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For FLOB.XBRU's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. FLOB.XBRU currently trades above its estimated intrinsic value and scores 54/100 on quality (mixed). It also yields about 0.3%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.